Greenwich Associates have published a paper which states that buyside firms could achieve significant savings on execution costs, up to 70% on some trades, by shifting some of their trading to listed FX options. In addition, for those impacted by uncleared margin rules (UMR), funding costs could be reduced by 86%.
Crucially, their total cost analysis (TCA) research also shows that listed FX options can be more cost-efficient alternatives to bilateral trading, independent of the incoming regulations, as the electronification of FX options accelerates and liquidity responds.
Avg of Majors | Short dated | Long dated | |||
---|---|---|---|---|---|
OTM | ATM | OTM | ATM | ||
1st level | spread | 1.72 | 2.16 | 1.97 | 2.56 |
size | $59 | $30 | $40 | $21 | |
2nd level | spread | 2.86 | 3.39 | 3.03 | 3.79 |
size | $97 | $55 | $69 | $42 |
The liquidity data for the EUR/USD book is provided below for comparative purposes. As expected, it has better than average liquidity than the other currencies, but not to an extent that it distorts the averaging process.
EURUSD | Short dated | Long dated | |||
---|---|---|---|---|---|
OTM | ATM | OTM | ATM | ||
1st level | spread | 1.62 | 1.93 | 2.00 | 2.44 |
size | $85 | $46 | $63 | $33 | |
2nd level | spread | 2.67 | 3.03 | 3.02 | 3.61 |
size | $179 | $103 | $127 | $69 |
One of the main benefits of an electronic central limit order book is that all participants can trade against all other participants (i.e. an all-to-all matching process), and furthermore all participants can choose to use limit orders (passive participation). This allows many participants to improve their execution price from the existing spread.
A significant proportion of buyside activity takes place inside the top-of-book spread at CME and this is observed in the percentage of buyside client volume traded in passive mode which averaged 55% in a recent six-month period. To estimate the value of passive trading, two further assumptions were made:
Benefit of limit orders on CME | Short dated | Long dated | |||
---|---|---|---|---|---|
OTM | ATM | OTM | ATM | ||
Pre | 1st lvl | 0.86 | 1.08 | 0.99 | 1.28 |
2nd lvl | 1.43 | 1.70 | 1.52 | 1.90 | |
Post | 1st lvl | 0.69 | 0.87 | 0.77 | 1.02 |
2nd lvl | 1.17 | 1.39 | 1.20 | 1.52 | |
Saving | 1st lvl | -20% | -19% | -22% | -21% |
2nd lvl | -18% | -18% | -21% | -20% |
Note: the table above shows spreads in $ pips expressed in terms of mid-to-bid or ask (i.e cost of trade should be relative to the mid-market at the time of the order going into the book).
Analysis Using SA-CCR Model Assumption | |||
---|---|---|---|
in thousands | Futures CME SPAN | Netted SIMM (PB) | Bilateral SIMM |
Funding Requirements | |||
Initial Margin (IM) | 7,987 | 22,806 | 74,431 |
IM as % of Notional | 0.8% | 2.3% | 2.6% |
Default Fund | 0 | 0 | 0 |
Total Funding | $7,987 | $22,806 | $74,431 |
Capital Requirements | |||
Leverage Ratio (SA-CCR) | 442 | 442 | 1,190 |
Default Fund | 0 | 0 | 0 |
CVA VaR | 18 | 19 | 48 |
Total Capital | $461 | $462 | $1,238 |
Annualized Costs | |||
Funding Costs | 160 | 456 | 1,489 |
Capital Costs | 46 | 46 | 124 |
CVA Costs | 64 | 68 | 168 |
LCR Costs | 40 | 114 | 372 |
Total Costs Annualized | $310 | $684 | $2,152 |
Cost differentials over CME: | +121% | +595% | |
Analysis Using CEM Model Assumption | |||
---|---|---|---|
in thousands | Futures CME SPAN | Netted SIMM (PB) | Bilateral SIMM |
Funding Requirements | |||
Initial Margin (IM) | 7,987 | 22,806 | 74,431 |
IM as % of Notional | 0.8% | 2.3% | 2.6% |
Default Fund | 0 | 0 | 0 |
Total Funding | $7,987 | $22,806 | $74,431 |
Capital Requirements | |||
Leverage Ratio (SA-CCR) | 198 | 198 | 576 |
Default Fund | 0 | 0 | 0 |
CVA VaR | 18 | 19 | 48 |
Total Capital | $216 | $217 | $624 |
Annualized Costs | |||
Funding Costs | 160 | 456 | 1,489 |
Capital Costs | 22 | 22 | 62 |
CVA Costs | 0 | 0 | 0 |
LCR Costs | 40 | 114 | 372 |
Total Costs Annualized | $221 | $592 | $1,923 |
Cost differentials over CME: | +168% | +770% | |
Assumptions: | ||
---|---|---|
Default Fund as % of IM | 5% | CME Ranges |
Funding Costs | 2.00% | CME Estimate |
Cost of Capital | 10% | CME Estimate |
Annualized CVA | 1.20% | CME Estimate |
LCR (based on Funding) | 0.5% | CME Estimate |
Default Fund C-Factor | 1% | CME Ranges |
CVA VaR multiplier | 0.34% | CME Estimate |
SA-CCR C/V Ratio | 125.0% | Over 100% indicates OC |
Margin Model Assumptions: MPOR | |
---|---|
Bilateral SIMM | 10 days |
Netted SIMM (PB) | 10 days |
Keep up-to-date with what’s happening in the FX marketplace. Sign up to receive product news, market trends, expert views, and statistics about our markets – from G10 to Emerging markets, across Futures, Options and FX Link.